Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir

CONCLUSIONS: Our study indicated an elevated HCC probability for entecavir-treated CHB patients with Non-MVR, especially for those with cirrhosis or a high predicted score at baseline. For MVR patients, the trajectories in ALT after virologic response suggested different HCC risks.PMID:34511012 | DOI:10.1080/17474124.2021.1980385
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: research